title: Obstructive sleep apnea syndrome as first manifestation of pharyngeal non-Hodgkin's lymphoma.
abstract: Obstructive sleep apnea syndrome (OSAS) is characterized by repetitive episodes of upper airway obstruction during sleep that provoke an abnormal number of apneas and hypopneas, leading to arousals and, as a result, to an altered sleep architecture. Here we present a patient with clinical symptoms characteristic of OSAS. During follow-up, pharyngeal non-Hodgkin's lymphoma was diagnosed and treated, with a nearly complete normalization of polysomnography.
authors.affiliation: Sección de Neumología, Hospital Universitario San Juan de Alicante, Alicante, Spain. gomez_eli@gva.es
authors.forename: Elia
authors.initials: E
authors.lastname: Gómez-Merino
authors.forename: Juan Manuel
authors.initials: JM
authors.lastname: Arriero
authors.forename: Eusebi
authors.initials: E
authors.lastname: Chiner
authors.forename: Jaime
authors.initials: J
authors.lastname: Signes-Costa
authors.forename: Juan
authors.initials: J
authors.lastname: Marco
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000150:complications* / Q000175:diagnosis* / Q000178:diet therapy; D008297:Male; D008875:Middle Aged; D010610:Pharyngeal Neoplasms / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D020181:Sleep Apnea, Obstructive / Q000209:etiology* / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone